Chang HH, Lee YC, Chen MF, Kuo JS, Lee TJ. Sympathetic activation increases basilar arterial blood flow in normotensive but not hypertensive rats. Am J Physiol Heart Circ Physiol 302: H1123-H1130, 2012. First published December 30, 2011 doi:10.1152/ajpheart.01016.2011The close apposition between sympathetic and parasympathetic nerve terminals in the adventitia of cerebral arteries provides morphological evidence that sympathetic nerve activation causes parasympathetic nitrergic vasodilation via a sympathetic-parasympathetic interaction mechanism. The decreased parasympathetic nerve terminals in basilar arteries (BA) of spontaneously hypertensive rat (SHR) and renovascular hypertensive rats (RHR) compared with Wistar-Kyoto rats (WKY), therefore, would diminish this axo-axonal interaction-mediated neurogenic vasodilation in hypertension. Increased basilar arterial blood flow (BABF) via axoaxonal interaction during sympathetic activation was, therefore, examined in anesthetized rats by laser-Doppler flowmetry. Electrical stimulation (ES) of sympathetic nerves originating in superior cervical ganglion (SCG) and topical nicotine (10 -30 M) onto BA of WKY significantly increased BABF. Both increases were inhibited by tetrodotoxin, 7-nitroindazole (neuronal nitric oxide synthase inhibitor), and ICI-118,551 (␤2-adrenoceptor antagonist), but not by atenolol (␤1-adrenoceptor antagonist). Topical norepinephrine onto BA also increased BABF, which was abolished by atenolol combined with 7-nitroindazole or ICI-118,551. Similar results were found in prehypertensive SHR. However, in adult SHR and RHR, ES of sympathetic nerves or topical nicotine caused minimum or no increase of BABF. It is concluded that excitation of sympathetic nerves to BA in WKY causes parasympathetic nitrergic vasodilation with increased BABF. This finding indicates an endowed functional neurogenic mechanism for increasing the BABF or brain stem blood flow in coping with increased local sympathetic activities in acutely stressful situations such as the "fight-or-flight response." This increased blood flow in defensive mechanism diminishes in genetic and nongenetic hypertensive rats due most likely to decreased parasympathetic nitrergic nerve terminals. axo-axonal interaction; basilar arterial blood flow; fight-or-flight response; spontaneously hypertensive rat; renovascular hypertensive rat GENERAL ACTIVATION OF THE sympathetic nerves that is commanded by the central autonomic neurons in the brain stem and hypothalamus is an essential defensive mechanism when animals and humans confront a life-threatening situation (20). Enhanced regional cerebral blood flow in the amygdala during visually elicited animal phobia reaction (1) and in the brain stem responding to anxiety stimulation (39, 40) has been reported for motor readiness to support the fight-or-flight response. It is, therefore, logical to suggest that increased neuronal activity in readiness for the fight-or-flight response most likely is accompanied by increased regional blood flow in the brain stem. This assumption and possible mechanism for increased brain stem blood flow in vivo, however, is not clarified.
axo-axonal interaction; basilar arterial blood flow; fight-or-flight response; spontaneously hypertensive rat; renovascular hypertensive rat GENERAL ACTIVATION OF THE sympathetic nerves that is commanded by the central autonomic neurons in the brain stem and hypothalamus is an essential defensive mechanism when animals and humans confront a life-threatening situation (20) . Enhanced regional cerebral blood flow in the amygdala during visually elicited animal phobia reaction (1) and in the brain stem responding to anxiety stimulation (39, 40) has been reported for motor readiness to support the fight-or-flight response. It is, therefore, logical to suggest that increased neuronal activity in readiness for the fight-or-flight response most likely is accompanied by increased regional blood flow in the brain stem. This assumption and possible mechanism for increased brain stem blood flow in vivo, however, is not clarified.
Cerebral blood vessels at the base of the brain from several species, including human, are known to receive vasoconstrictor and dilator nerves (3, 8, 31) . Norepinephrine (NE) released from the sympathetic adrenergic nerves originating in the superior cervical ganglion (SCG) and acetylcholine (ACh) from the parasympathetic cholinergic nerves originating in multiple sources, including the sphenopalatine ganglion, were originally suggested as the respective transmitters for vasoconstriction and dilation (3, 8, 31, 44, 49) . The wide sympathetic synaptic distance and insensitivity of the ␣-and ␤-adrenoceptors (31) on the smooth muscle cells to NE in basilar arteries suggest that endogenous NE, which is released from sympathetic nerves (7, 31) , plays a minimum role in directly affecting the smooth muscle tone of basilar arteries.
The unique feature of the close apposition between perivascular sympathetic and parasympathetic nerve terminals in large arteries at the base of the brain in different species is well established (8, 28) . This finding leads to the proposed axoaxonal interaction hypothesis indicating that NE released from the sympathetic nerves innervating the basilar arteries acts on the ␤ 2 -adrenoceptors located on the neighboring parasympathetic nitregic nerves to facilitate nitric oxide (NO) release, resulting in vasorelaxation (31, 43) . Thus, NE acts as a presynaptic transmitter in positively modulating NO release. These results suggest an endowed mechanism for increased blood flow in the brain stem during enhanced sympathetic activity.
This functional axo-axonal interaction in regulating cerebral circulation may change in chronic hypertension. This is based on reported results that distribution of cerebral perivascular sympathetic and parasympathetic nerve terminals changes in hypertension (30, 31, 42) . The density of the sympathetic nerve terminals increases in the spontaneously hypertensive rat (SHR) but decreases in the renovascular hypertensive rat (RHR). On the other hand, density of the parasympathetic nerve terminals significantly decreases in cerebral arterial walls of both SHR (30) and RHR (42) . These results suggest that the sympathetic-parasympathetic interaction leading to increased cerebral neurogenic nitrergic vasodilation and blood flow at the base of the brain upon sympathetic activation will diminish in both the SHR and RHR in vivo. In the present study, effects of electrical and chemical activations of the sympathetic nerves on the basilar arterial blood flow (BABF) in the normotensive Wistar-Kyoto (WKY), SHR, and RHR, therefore, were examined using the cranial window technique. Our results indicated that activation of cerebral perivascular sympathetic nerves by electrical stimulation (ES) or topical nicotine onto basilar arteries caused predominant nitrergic dilation of the basilar arteries with enhanced blood flow in the WKY, while no increase in vasodilation or blood flow was found in adult SHR and RHR with established hypertension.
MATERIALS AND METHODS
All animal protocols were approved by the Laboratory Animal Care and Use Committee at Tzu Chi University.
General procedure. Male WKY (6 -25 wk old) and male SHR (6 -25 wk old) were anesthetized with urethane (500 mg/kg ip) and chloralose (50 mg/kg ip). Both preganglionic cervical sympathetic trunks on both sides of the animal were exposed, separated from the common carotid artery and the vagus nerve (4) . After the completion of a tracheotomy, the animals were ventilated mechanically with room air mixed with 100% oxygen. A catheter was placed in the right femoral artery for withdrawing blood for the measurement of arterial blood gases and pH. Arterial blood gases and pH were monitored and maintained within normal ranges throughout the experiment (PCO 2 ϭ 38 Ϯ 1 mmHg, PO2 ϭ 120 Ϯ 3 mmHg, and pH ϭ 7.36 Ϯ 0.01). The left femoral artery and vein were cannulated for monitoring mean arterial blood pressure (MAP) with a Powerlab polygraph (ADInstruments, Castle Hill, Australia) and for infusing drugs, respectively. Rectal temperature was maintained between 37 and 38°C with a heating pad (9, 56) .
Measurement of the BABF. After placement of all catheters, the animal was placed in a head holder in a supine position. The larynx and esophagus were retracted rostrally and laterally, and the musculature covering the basioccipital bone was removed (9) . A small hole of 0.7 cm in diameter was made in the basioccipital bone with an air-cooled drill. The dura and a thin bone layer were removed. The basilar artery can be seen through this hole. The cranial window was suffused, with a peristaltic pump, with artificial cerebral spinal fluid (ACSF, 38°C), which was aired continuously with 95% O 2 and 5% CO2 to maintain normal gas ranges (PCO2 ϭ 37 Ϯ 1 mmHg, PO2 ϭ 128 Ϯ 3 mmHg, pH ϭ 7.37 Ϯ 0.01) throughout the experiment. The composition of the ACSF (in mM) was 131.9 NaCl, 3.7 glucose, 6.7 urea, 3 KCl, 0.6 MgCl 2, 1.5 CaCl2, and 24.6 NaHCO3 (36). The BABF was monitored using an OxyLab LDF/OxyFlo laser-Doppler flowmeter equipped with a Ͼ500-m-diameter needle probe (OxyFlo; Oxford Optronix, Oxford, OX, UK). The probe was placed lateral to, but near, the basilar artery in the cranial window and advanced into the ACSF ϳ0.2 mm above the surface of the brain stem. It is important that the laser-Doppler probe projection area cover the change of basilar arterial diameter (51) . Thus, blood flow within the basilar artery was measured. After craniotomy, the basilar artery was allowed to equilibrate for 30 min before BABF examination. The resting BABF and its relative changes were measured before and after ES (1, 2, 4, and 8 Hz with 2-ms pulse duration, 1 volt, and 1-s stimulation) of the SCG or topical application of nicotine (10 and 30 M), ACh (0.1 and 1 M), or NE (0.1 and 1 M) directly onto the basilar arteries. Our preliminary studies showed that ES of the sympathetic nerves increased BABF, reaching peak steady state in 30 s, whereas topical nicotine, NE, and ACh, reached peak steady state in Ͻ3 min. We therefore applied all experimental drugs continuously for 5 min, and the percent changes in BABF at the 5th min were reported. A 15-min recovery period after each ES or administration of experimental drugs was allowed for the BABF to return to the baseline. Effects of 7-nitroindazole [7-NI, a neuronal nitric oxide synthase (NOS) inhibitor, 25 mg/kg ip], atenolol (a ␤ 1-adrenoceptor antagonist, 10 mg/kg iv), ICI-118,551 (a ␤2-adrenoceptor antagonist, 10 mg/kg iv or 10 M, topical application onto basilar artery), tetrodotoxin (TTX, 1 M, topical application), and N G -nitro-L-arginine (L-NNA, 100 M, topical application) on BABF were examined. Each blocker was applied 15 min before repeating ES or application of nicotine. Our standard experiment involved three control ES or nicotine applications 30 min apart before conducting drug effects. This serves as a time control. Changes in diameter and BABF in the first three times upon ES of the sympathetic nerves were reproducible. Sympathetic denervation. Male WKY rats were anesthetized with pentobarbital sodium (55 mg/kg ip). A midline incision was made on the skin longitudinally on top of the larynx. Blunt dissection technique of the muscle and fat tissues was performed to expose the carotid artery. The SCG at the bifurcation of the internal and external carotid arteries was exposed and severed with scissors of postganglionic nerves (27) . The procedure was performed on both SCG of the rat. Five days after surgical denervation, animals were used for measurement of BABF. The successful denervation was verified by complete disappearance of catecholamine fluorescence on the basilar artery (27) .
Renovascular hypertension. The RHR (2-kidney 1-clip) was performed on 5-wk-old male Sprague-Dawley rats (body wt 150 -200 g) under pentobarbital anesthesia (55 mg/kg body wt ip) by placing a silver clip (internal diameter, 0.25 mm) on the left renal artery. The contralateral kidney was left untouched. MAP was measured two times a week by means of a tail cuff (BP Monitor Model MK-200; Muromachi KIKAI, Tokyo, Osaka, Japan). Animals subjected to sham operation, in which the left kidney was exposed and the left renal artery was stripped, served as normotensive controls (11, 42) . Four weeks after operation, the RHRs with MAP Ͼ150 mmHg were considered hypertensive.
Drugs used and statistical analysis. The following chemicals were used: NaCl, NaHCO 3, KCl, CaCl2, MgCl2, and glucose (all from Amresco, Solon, OH); and urea, sodium nitroprusside, nicotine, ICI-118,551, atenolol, urethane, chloralose, TTX, ACh, NE, 7-NI, L-NNA, and sodium nitroprusside (all from Sigma-Aldrich, St. Louis, MO). A paired t-test was used to compare difference in the same animals. A one-way ANOVA followed by Dunnett's multiple-comparison tests was used to compare difference between different animals. All values are presented as means Ϯ SD. A value of P Ͻ 0.05 was considered statistically significant.
RESULTS

ES of sympathetic nerve-and nicotine-induced increase of the BABF.
In 6-wk (MAP 103.4 Ϯ 4.9 mmHg, n ϭ 6) and 12-wk (MAP 119.6 Ϯ 2.7 mmHg, n ϭ 6)-old WKY, ES at 1, 2, 4, and 8 Hz of the SCG in a frequency-dependent manner significantly increased the BABF (Fig. 1A) without affecting the MAP (data not shown). In 24-wk-old WKY (MAP 110.1 Ϯ 6.3 mmHg, n ϭ 6), ES at various frequencies, which did not affect the MAP (data not shown), also significantly increased the BABF similar to that found in 6-wk-old WKY except that no significant increase of BABF was found by 1 or 8 Hz of stimulation (Fig. 1A) . Topical application of nicotine (10 and 30 M, n ϭ 6) directly onto basilar arteries, which did not affect the MAP, concentration-dependently increased the BABF (Fig. 1B) . Also, the diameter of the basilar artery significantly increased upon ES and topical nicotine (Fig. 1C) . In chronically sympathetically denervated basilar arteries, ES or topical nicotine did not affect the basal BABF (Fig. 1D) , whereas topical applications of ACh (1 M) still induced a significant increase of the BABF like that found in the normal control animals (n ϭ 5, Fig. 1D) .
Blockade by the neuronal NOS inhibitor of increased BABF elicited by ES of sympathetic nerves and topical nicotine.
Increased BABF elicited by ES (4 Hz) and nicotine (30 M, topical) was significantly inhibited by TTX (1 M, topical application), 7-NI (25 mg/kg ip), and L-NNA (a nonselective NOS inhibitor, 100 M, topical application) ( Fig. 2A) , which did not affect the MAP (data not shown). Increased BABF upon topical application of ACh was not affected by TTX or 7-NI but was abolished by L-NNA (n ϭ 6, Fig. 2A ). The increased BABF induced by ES (4 Hz) or topical nicotine was not affected by atenolol (10 mg/kg iv) but was significantly inhibited by ICI-118,551 (10 mg/kg iv) (n ϭ 5, Fig.  2B ). Both antagonists at similar concentrations did not affect the MAP (data not shown), nor did they affect the increased BABF induced by topical applications of ACh (1 M) (Fig. 2B) .
Exogenous NE-induced increase of the BABF. Topical application of NE (1 M) onto the basilar artery increased the BABF. The increase was partially and significantly inhibited by atenolol (10 mg/kg iv) (Fig. 3, A and B) and was completely inhibited by combined atenolol and ICI-118,551 (10 M, topical application) (Fig. 3, A and B) or combined atenolol and 7-NI (25 mg/kg ip) (n ϭ 6, Fig. 3B ). Atenolol alone or its combinations did not affect the MAP (Fig. 3A) or the increased BABF induced by topical ACh (1 M) (Fig.  3B) . NE-induced increase of the BABF was not affected by TTX (1 M, topical application) or ICI-118,551 (10 mg/kg iv) alone (Fig. 3C) .
Failure of ES of sympathetic nerve and topical nicotine to increase the BABF in the hypertensive rats. In 6-wk-old prehypertensive SHR (MAP, 105.8 Ϯ 2.9 mmHg, n ϭ 10), ES at 1, 2, and 4 Hz of the SCG and topical nicotine (0.3, 10, and 30 M) in a frequency-dependent (n ϭ 5, Fig. 4A ) and a concentration-dependent (n ϭ 5, Fig. 4B ) manner significantly increased the BABF without affecting the MAP (data not shown). In normotensive Sprague-Dawley rats (MAP 117.3 Ϯ 10.6 mmHg, 9 wk old), ES (4 Hz) and topical nicotine (30 M) also significantly increased the BABF (Fig. 4C) . The increase following ES or topical nicotine was blocked by 7-NI (25 mg/kg ip) alone or ICI-118,551 (10 mg/kg iv) alone (n ϭ 5, Fig. 4D ), which did not affect the MAP (data not shown). On the other hand, in 12-and 24-wk-old SHR (MAP 148.6 Ϯ 28.6 and 164.1 Ϯ 5.4 mmHg, respectively, n ϭ 5) and 9-wk-old RHR (MAP 161.25 Ϯ 10.1 mmHg, n ϭ 3), ES at any frequency (1, 2, 4, and 8 Hz) (Fig. 4, A and C) or topical application of nicotine (0.3, 10, and 30 M, n ϭ 5) (Fig. 4, B and C) did not significantly increase the BABF. In these 12-and 24-wk-old rats, topical sodium nitroprusside (0.1 mM) still increased BABF, which was not smaller than that of the 6-wk-old SHR (n ϭ 5, Fig. 4A ). 
DISCUSSION
The present study demonstrated for the first time that activation of sympathetic neurons of the SCG origin in vivo caused parasympathetic nitrergic dilation of the basilar arteries with increased BABF in the WKY. This functional axo-axonal interaction mechanism in sympathetic nerve-elicited nitrergic vasodilation significantly diminished in genetic and nongenetic established hypertension.
The large arteries at the base of the brain in all species, including human, receive dense sympathetic and parasympathetic innervations (3, 6, 8, 31, 45) . The functional role of these innervations in controlling regional cerebral circulation, however, remains debatable due to inconsistent results obtained in animal studies (4, 16, 34, 35, 36) . Most recent studies in humans using the transcranial Doppler ultrasound techniques, however, have demonstrated that the autonomic innervation is functional in dynamic regulation of the cerebral blood flow (14, 34) .
General agreement has been that cerebral perivascular sympathetic and parasympathetic nerves mediate vasoconstriction and dilatation, respectively (14, 27, 31, 49) . Exceptions, however, exist due to regional variations in innervation patterns and neurovascular transmission mechanisms (12, 31) . For example, the smooth muscle cells of basilar arteries of most species, including human, contain predominant ␣-adrenoceptors and constrict upon application of NE (27, 31, 49) . NE, however, induces exclusive relaxation of the rat and pig basilar arteries due to the presence of predominant ␤ 1 -adrenoceptors on the smooth muscle cells of these arteries (23, 29) . Regardless of species variations of adrenoceptor subtypes on vascular smooth muscle cells, NE released from perivascular sympathetic nerves on the basilar arteries of several experimental animals causes very small or no direct response of the smooth muscle cells (27, 29, 31) . These results suggest that NE is a very weak postsynaptic transmitter (31). /kg iv, A and B) , and was almost completely inhibited by atenolol plus 7-NI (25 mg/kg ip, n ϭ 7, B) and atenolol plus ICI-118,551 (10 M, topical, n ϭ 6, A and B). These inhibitors, which did not significantly affect the MAP, did not affect the increased BABF induced by topical ACh (1 M, B) . The increased BABF induced by NE was not affected by TTX (1 M, topical, n ϭ 3, C) or ICI-118,551 (10 mg/kg iv, n ϭ 3, C). BP, blood pressure. Values are means Ϯ SD. ␦P Ͻ 0.05, significant difference from the increased BABF in B. In isolated basilar arteries of the pigs and cats, activation by nicotinic agonists of nicotinic acetylcholine receptors (nAChR) located on perivascular sympathetic nerves results in parasympathetic nitrergic neurogenic vasodilation (31, 43) . Specifically, NE released from the cerebral perivascular sympathetic nerves upon activation of the nAChR acts as a presynaptic transmitter on the ␤ 2 -adrenoceptor located on the neighboring parasympathetic nitrergic nerve terminals, causing release of NO and vasodilation (43; Fig. 5 ). This axo-axonal interaction mechanism in mediating sympathetic nerve-initiated nitrergic vasodilation of isolated basilar arteries is supported by results of the present in vivo study. ES of sympathetic nerves and topical nicotine onto basilar arteries increased basilar arterial diameter and the BABF, and both increases were inhibited by the NOS inhibitor TTX and chronic sympathetic surgical denervation of basilar arteries. Because topical nicotine did not induce appreciable responses of the diameter or blood flow of the basilar arteries following chronic sympathetic dennervation, the possibility that topical nicotine-induced vasodilation and increased BABF is resulted from release of any mediators by nicotine from the brain stem neurons and/or the endothelium (53) is ruled out.
The role of parasympathetic ␤ 2 -adrenoceptor in mediating NE-elicited nitrergic vasodilation (31, 43; Fig. 5 ) also is supported by the present findings that increased BABF elicited by ES of sympathetic nerves or topical nicotine was inhibited by ␤ 2 -adrenoceptor antagonist but was not affected by ␤ 1 -adrenoceptor antagonist alone. This is further supported by results from studying vasodilation induced by exogenous NE. Consistent with the report that rat basilar arterial smooth muscle cells are endowed with ␤ 1 -adrenoceptors (23, our unpublished results), the increased BABF upon topical application of NE onto the rat basilar arteries was partially and significantly inhibited by atenolol alone but not by ICI-118,551 alone. The increase, however, was abolished by combined atenolol and ICI-118,551, or atenolol and 7-NI. These findings are consistent with the hypothesis that exogenous NE-induced increase of the BABF is by acting on ␤ 1 -adrenoceptors on the basilar arterial smooth muscle cells (Fig. 5 ) and the ␤ 2 -adrenoceptors on perivascular parasympathetic nitrergic nerve terminals causing release of NO (31) .
It is interesting to note that the optimal stimulation frequency of ES of sympathetic nerves to increase BABF is 4 Hz in all ages of rats examined. At higher frequency (8 Hz), the increased BABF elicited by ES began to decline, especially, in older rats (24 wk old). This is not likely due to increased release of NE at 8 Hz, which may in contrary induce greater relaxation since the smooth muscle cells are predominantly endowed with ␤ 1 -adrenoceptors (23) . The exact reason for the difference is not known. It is well established that NO and ACh are coreleased in cerebral perivascular nitrergic nerves in the cats (22) , pigs (31, 56) , and rats (32) . Upon electrical depolarization of the perivascular nerves in pig basilar arteries, neurogenic vasodilation is mainly due to released NO, whereas the cotransmitter ACh acts on the prejunctional muscarinic M 2 receptors to negatively modulate NO release (31, 33, 37) . Meanwhile, nitrergic vasodilation of porcine basilar arteries induced by nicotine activation of sympathetic nerve is not accompanied by ACh release (31, 37, 43) . It is possible that release of NO and ACh from the same neurons is dependent on different mechanisms and is variable depending on frequencies of ES and ages of the animals. While it remains to be determined, this possibility is supported by the present finding that increased BABF induced by topical nicotine is not different between 12-and 24-wk-old rats.
The unique close apposition of the cerebral perivascular sympathetic and parasympathetic nerves in different species (8, 19, 28, 31, 7, 23, 26) provides morphological basis for axoaxonal interaction in regulating cerebral vascular tone (31) . Any change of morphological distributions of these nerve terminals, therefore, would alter the axo-axonal interaction mechanism and the vascular response. It has been shown that the sympathetic nerve terminals in large arteries at the base of the brain of adult SHR significantly increase while that in the RHR decrease compared with those of age-matched WKY (30, 31, 42) . On the other hand, the parasympathetic nerve terminals in large cerebral arteries of both SHR (30) and RHR (42) decrease. Because almost all perivascular parasympathetic nerves to arteries at the base of the brain contain NOS (22, 32, 57) and that responses of cerebral vascular smooth muscle to NO are not significantly impaired in chronic hypertension (present result; 55), altered (increase or decrease) sympathetic nerve terminals and/or decreased parasympathetic nerve termi- Fig. 5 . Close apposition of an adrenergic nerve terminal of the SCG origin and a cholinergic-nitrergic nerve terminal originating in the sphenopalatine ganglion (SPG) and their relationship to smooth muscle cells in arteries at the base of the brain. This structural organization provides a morphological basis for an axo-axonal interaction in neurogenic regulation of the basilar arterial diameter and blood flow. NE, released upon activation by nicotinic agonists of the nicotinic acetylcholine receptor (nAChR) located on perivasculr sympathetic nerves, acts on ␤2-adrenoceptors located on neighboring parasympathetic nitrergic nerves, causing release of nitric oxide (NO), which then acts on soluble guanylyl cyclase (sGC) to enhance cGMP synthesis and vasodilation with increased BABF. NO is synthesized from L-arginine (L-Arg) catalyzed by nitric oxide synthase (NOS) with L-citrulline (L-Cit) as the byproduct. Activation by ACh of the muscarinic ACh receptor (M) on the endothelial cells also releases NO. Endogenous NE does not (indicated by dotted line) significantly affect the basilar arterial smooth muscle cell (SMC), which is endowed primarily with ␤1-adrenoceptors. The axo-axonal interaction is altered due to decreased parasympathetic cholinergic-nitrergic nerve terminals in hypertension, leading to diminished nitrergic vasodilation and BABF. nals in established hypertension would impair the sympatheticparasympathetic interaction mechanism, leading to diminished nitrergic vasodilation. Indeed, this hypothesis is supported by results of the present study that ES of the sympathetic nerves and topical nicotine onto the basilar arteries did not significantly increase diameter of the basilar arteries or the BABF in hypertensive SHR and RHR, whereas similar stimulating parameters increased the TTX-and 7-NI-sensitive BABF in the normotensive prehypertensive SHR and WKY. In this regard, it is interesting to note that impaired autoregulatory dilation of the basilar artery has been demonstrated in adult SHR (51) .
Although the pathophysiological mechanism for decreased parasympathetic nerve terminals in basilar arteries of hypertensive rats (30, 42) remains unknown, it is possible that decreased function of the ␤ 2 -adrenoceptors located on nitrergic nerve terminals (Fig. 5 ) of the basilar artery may lead to blunted responses of the axo-axonal interaction mechanism in hypertensive animals. This, however, is not likely. Several studies have demonstrated that neuronal ␤ 2 -adrenoceptors in the central nervous system and on the autonomic nerve terminals are fully functional in early and established hypertension with similar ages of the SHRs used in the present study. For example, we have demonstrated that sympathetic presynaptic ␤ 2 -adrenoceptor-mediated facilitation of neurogenic pressor response in mesenteric arteries is enhanced in 4-wk-old prehypertensive SHR (52) . Also, ␤ 2 -adrenoceptors in the posterior hypothalamus are actively involved in mediating the increased renal sympathetic nerve activity and antinatriuresis resulting from environmental stress in maintaining hypertension in 16-wk-old conscious SHR (25) . These results suggest that the blunted responses in hypertensive animals are not likely due to dysfunction of ␤ 2 -adrenoceptors on nitrergic nerve terminals. Because distensibility as indicated by NO-induced relaxation of the smooth muscle in the SHR is not altered either, it further favors that the decrease of perivascular parasympathetic nitrergic nerve terminals is responsible for the interruption of the sympathetic-parasympathetic interaction mechanism in the basilar arteries of the SHR and RHR and, therefore, the blunted neurogenic response of the basilar arteries with diminished increase of the BABF induced by activation of the sympathetic nerves.
It is generally believed that activation of sympathetic nerves decreases cerebral pial arterial diameter in the rat and cat (26, 35, 54) and adult human (2) . This is different from the present findings of increased blood flow in the large arteries at the base of the brain upon activation of sympathetic nerves. It appears that regional variations in vascular responses exist following sympathetic nerve activation in all species. This may be explained in part by innervation patterns of the perivascular sympathetic and parasympathetic neurons. For example, pial arteries in parietal cortex, unlike that in basilar arteries, receive mainly sympathetic nerves and very few, if any, parasympathetic nitrergic nerves (our preliminary results; 30). This morphological finding indicates that functional axo-axonal (sympathetic-parasympathetic) interaction leading to vasodilation does not operate in this region, and sympathetic activation may cause vasoconstriction. It is logical from a physiological point of view that activation of sympathetic nerves of the SCG origin causes vasodilation with increased blood flow in large arteries at the base of the brain such as the basilar artery and simultaneous vasoconstriction with decreased blood flow, if any, in the downstream parietal region. Thus, an adrenergic increase in blood flow in large arteries at the base of the brain can counterbalance against simultaneous adrenergic increases in downstream arteriolar resistance.
Whether or not the axo-axonal interaction mechanism is operating in neurogenic control of the BABF in the human is not known. Human basilar arteries also receive sympathetic (3, 21) and nitrergic neurons (45, 50) , which are functional in regulating the cerebral circulation (2, 38, 46) . Reports by many indicate that cigarette smoking frequently increases cerebral blood flow (5, 24) . This finding is most reasonably explained by the presence of a functional axo-axonal interaction mechanism like that found in the rat (17) , since exogenous NE induces ␣-adrenoceptor-mediated constriction of human basilar arteries (15, 49) . Consistent to this assumption is that increased sympathetic activities during stress and anxiety are accompanied by enhanced brain stem blood flow (39) .
In summary, large cerebral arteries are important determinants of local microvascular pressure and also contribute significantly to total cerebral resistance (10) . Accordingly, change of blood flow in a large artery like the basilar arteries is an indication of the blood flow in the brain stem. Results of the present in vivo study are consistent with the findings from previous studies using isolated basilar arteries (31, 43) indicating that activation of the sympathetic nerves of the SCG origin by electrical or chemical depolarization increases the BABF via an axo-axonal interaction mechanism (Fig. 5) . The reported decrease of parasympathetic nerve terminals in adult SHR and RHR is accompanied by diminished sympathetic nerve-initiated nitrergic vasodilation and increased BABF. These results further support the functional significance of the axo-axonal interaction mechanism in providing physiological regulation of blood flow in the brain stem region in many species, probably, including humans. This axo-axonal interaction mechanism may play a critical role in mediating increased BABF during acute stress conditions such as the fight-or-flight response. These results also provide additional evidence that cerebral perivascular autonomic innervations are functional in regulating cerebral blood flow. The exact mechanisms and consequence of the diminished increase of the BABF in defensive mechanisms in genetic and nongenetic hypertension deserve further investigation.
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